Business
SERA PROGNOSTICS PRESENTATION RESCHEDULED FOR CITI 2022 HEALTHCARE CONFERENCE
SALT LAKE CITY, Feb. 17, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
About this update from Sera Prognostics, Inc.
[{"type":"text","content":"SALT LAKE CITY, Feb. 17, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that its presentation at the virtual Citi 2022 Healthcare Conference: Services, MedTech, Life Science Tools & HCIT, to be held February 23-24, 2022, has been rescheduled. Gregory C. Critchfield, M.D., M.S., Chairman and CEO, will provide a company update and discuss Sera's latest achievements. Sera's management will also be available for one-on-one meetings with investors.\n\n \n \n \n \n \n \n\n \nCiti 2022 Healthcare Conference: Services, MedTech, Life Science Tools & HCIT\nSera's management will participate in a Citi fireside chat on Thursday, February 24, 2022 that has been rescheduled to begin at 9:30 a.m. EST. A live webcast of the company's presentation will be available on the Investors section of the Sera Prognostics website. A webcast replay will not be available.\nAbout Sera Prognostics, Inc.\nSera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to deliver early, pivotal information in pregnancy to physicians, enabling them to improve the health of their patients, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is located in Salt Lake City, Utah.\nAbout Preterm Birth\nPreterm birth is defined as any birth before 37 weeks' gestation and is the leading cause of illness and death in newborns. The 2021 March of Dimes Report Card shows that more than one in ten infants is born prematurely. Prematurity is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, and vision and hearing loss, and can generate significant costs throughout the lives of ...